Whittier Trust Co. of Nevada Inc. Buys 1,469 Shares of The Allstate Co. (NYSE:ALL)

Whittier Trust Co. of Nevada Inc. grew its stake in The Allstate Co. (NYSE:ALL - Free Report) by 28.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,556 shares of the insurance provider's stock after buying an additional 1,469 shares during the quarter. Whittier Trust Co. of Nevada Inc.'s holdings in Allstate were worth $1,264,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Holderness Investments Co. bought a new stake in shares of Allstate in the fourth quarter worth $243,000. Blueshift Asset Management LLC lifted its position in Allstate by 103.7% during the 4th quarter. Blueshift Asset Management LLC now owns 6,688 shares of the insurance provider's stock worth $1,289,000 after buying an additional 3,405 shares in the last quarter. Teacher Retirement System of Texas boosted its stake in shares of Allstate by 116.2% during the 4th quarter. Teacher Retirement System of Texas now owns 351,206 shares of the insurance provider's stock worth $67,709,000 after buying an additional 188,753 shares during the last quarter. VSM Wealth Advisory LLC bought a new position in shares of Allstate in the 4th quarter valued at about $25,000. Finally, Xponance Inc. increased its position in shares of Allstate by 36.2% in the fourth quarter. Xponance Inc. now owns 54,962 shares of the insurance provider's stock valued at $10,596,000 after acquiring an additional 14,604 shares during the last quarter. Institutional investors own 76.47% of the company's stock.

Allstate Stock Performance

Shares of ALL stock traded up $0.10 on Thursday, hitting $209.38. The company's stock had a trading volume of 1,827,467 shares, compared to its average volume of 1,496,044. The Allstate Co. has a fifty-two week low of $156.66 and a fifty-two week high of $212.91. The company has a market capitalization of $55.49 billion, a PE ratio of 12.32, a PEG ratio of 1.01 and a beta of 0.47. The stock's 50 day moving average is $195.10 and its 200-day moving average is $193.54. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36.

Remove Ads

Allstate (NYSE:ALL - Get Free Report) last announced its earnings results on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, topping the consensus estimate of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. Equities research analysts expect that The Allstate Co. will post 18.74 earnings per share for the current fiscal year.

Allstate declared that its Board of Directors has initiated a stock buyback plan on Wednesday, February 26th that allows the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization allows the insurance provider to buy up to 3% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's board believes its stock is undervalued.

Allstate Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 10th will be issued a dividend of $1.00 per share. This is a positive change from Allstate's previous quarterly dividend of $0.92. This represents a $4.00 annualized dividend and a dividend yield of 1.91%. The ex-dividend date is Monday, March 10th. Allstate's dividend payout ratio is 23.54%.

Insider Buying and Selling

In related news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the sale, the chief financial officer now owns 18,115 shares in the company, valued at approximately $3,378,990.95. This trade represents a 68.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.80% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research firms have weighed in on ALL. Barclays decreased their price target on Allstate from $187.00 to $183.00 and set an "underweight" rating for the company in a research note on Monday, January 6th. Argus upgraded shares of Allstate from a "hold" rating to a "buy" rating in a report on Monday, March 3rd. Keefe, Bruyette & Woods increased their price target on shares of Allstate from $235.00 to $240.00 and gave the company an "outperform" rating in a research note on Tuesday, February 11th. Evercore ISI raised shares of Allstate from an "in-line" rating to an "outperform" rating in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company upped their target price on shares of Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a report on Tuesday, January 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Allstate has a consensus rating of "Moderate Buy" and an average target price of $217.94.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.